Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell (CTC) and other rare cell capture from biological samples. The IsoFlux Rare Cell ...
Fluxion Biosciences has introduced an instrument to isolate rare circulating tumor cells (CTC) which disseminate from primary tumors and circulate throughout the peripheral blood. Using the proprietary microfluidic technology, the IsoFlux ...
Tags: CTC instrument, IsoFlux System, medical device, Class I medical device